Publication | Closed Access

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

Systemic Th2 ResponseCancer ImmunosurveillanceIl-10 ExpressionT-regulatory CellImmunologyTumor ImmunityImmunologic MechanismAutoimmunityImmunotherapyMedicineCell BiologyTumor MicroenvironmentMalignant Phenotype